HomeCompareCFOK vs MRK

CFOK vs MRK: Dividend Comparison 2026

CFOK yields 25.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $33.4K in total portfolio value· pulled ahead in Year 4
10 years
CFOK
CFOK
● Live price
25.00%
Share price
$8.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.3K
Annual income
$3.01
Full CFOK calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CFOK vs MRK

📍 MRK pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCFOKMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CFOK + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CFOK pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFOK
Annual income on $10K today (after 15% tax)
$2,125.00/yr
After 10yr DRIP, annual income (after tax)
$2.56/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,594.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFOK + MRK for your $10,000?

CFOK: 50%MRK: 50%
100% MRK50/50100% CFOK
Portfolio after 10yr
$41.0K
Annual income
$5,058.40/yr
Blended yield
12.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CFOK
No analyst data
Altman Z
-0.6
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFOK buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCFOKMRK
Forward yield25.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$24.3K$57.7K
Annual income after 10y$3.01$10,113.78
Total dividends collected$2.7K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CFOK vs MRK ($10,000, DRIP)

YearCFOK PortfolioCFOK Income/yrMRK PortfolioMRK Income/yrGap
1$11,950$1,250.00$11,213$373.04+$737.00CFOK
2$13,485$698.01$12,667$512.06+$818.00CFOK
3$14,796$368.06$14,439$708.14+$357.00CFOK
4← crossover$16,021$188.72$16,640$988.16$619.00MRK
5$17,238$95.49$19,432$1,394.07$2.2KMRK
6$18,493$48.01$23,057$1,992.90$4.6KMRK
7$19,811$24.07$27,889$2,894.79$8.1KMRK
8$21,210$12.05$34,518$4,286.29$13.3KMRK
9$22,701$6.03$43,912$6,494.35$21.2KMRK
10$24,293$3.01$57,714$10,113.78$33.4KMRK

CFOK vs MRK: Complete Analysis 2026

CFOKStock

Community First Bancorporation operates as the bank holding company for Community First Bank that provides commercial banking products and services to personal and business customers. The company offers various deposit products, including checking accounts, NOW accounts, individual retirement accounts, time deposits, and money market accounts and certificates of deposit. It also provides commercial loans, including short term unsecured loans, short and intermediate term real estate mortgage loans, and loans secured by listed stocks, as well as loans secured by equipment, inventory, and accounts receivable; consumer loans, such as home equity improvement loans secured by first and second mortgages, personal expenditure loans, education loans, and overdraft lines of credit, as well as car, recreational vehicle, and boat loans; and debit and credit card services. In addition, the company offers direct deposit, foreign payment and currency exchange, electronic bill payment, remote check deposit, merchant, and other related services; internet and mobile banking services; and life, home, auto, health, and pet insurance products. It operates through eight full-service offices in Walhalla, Seneca, Anderson, Williamston, Westminster, and Greenville, South Carolina, as well as two in North Carolina; and loan production offices in Charlotte and Concord, North Carolina. Community First Bancorporation was founded in 1988 and is based in Walhalla, South Carolina.

Full CFOK Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CFOK vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFOK vs SCHDCFOK vs JEPICFOK vs OCFOK vs KOCFOK vs MAINCFOK vs JNJCFOK vs ABBVCFOK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.